Arcturus Therapeutics Holdings Inc (ARCT)
SG&A Expense Growth
24.78%
Quarterly · Period ending:
ARCT SG&A Expense Growth
Latest reported24.78%period ending
Latest reported24.78%period ending
ARCT Quarterly SG&A Growth (QoQ) (0.00% → 24.78%)
Latest values, visible window
High-resolution chart · PNG
ARCT sg&a expense growth history
Quarterly. Dates are reporting period ends; fiscal years can differ from calendar years.
| Period ending | SG&A Expense Growth |
|---|---|
| 24.7757% | |
| -37.2139% | |
| 34.9009% | |
| 0.5804% | |
| -8.6346% | |
| -8.6026% | |
| -6.749% | |
| 7.7947% | |
| -17.0696% | |
| 18.7415% | |
| -6.5037% | |
| 1.1493% | |
| -3.902% | |
| 16.0371% | |
| -5.0288% | |
| 13.5996% | |
| 2.4511% | |
| -15.5517% | |
| 16.9982% | |
| 8.1458% | |
| 3.0689% | |
| -10.8926% | |
| 96.2312% | |
| 26.0633% | |
| 5.4641% | |
| 0% | |
| 7.9876% | |
| 12.2975% | |
| -2.2071% | |
| 2.7027% | |
| -9.685% | |
| -53.7228% | |
| 61.4947% | |
| 92.0151% | |
| 61.3001% | |
| -21.2817% | |
| 77.2034% | |
| -8.2426% | |
| 6.1932% | |
| -13.6234% | |
| -3.8409% | |
| 10.0377% | |
| 12.6701% | |
| -2.1631% | |
| -6.7494% | |
| -10.2368% | |
| 13.4281% | |
| -6.0831% | |
| -24.6506% | |
| 72.0192% | |
| -2.7128% | |
| 22.1714% | |
| 266.1088% | |
| 31.3187% | |
| 25.5172% | |
| -26.7677% | |
| 0% |